Literature DB >> 15255761

Tissue engineering applications of therapeutic cloning.

Anthony Atala1, Chester J Koh.   

Abstract

Few treatment options are available for patients suffering from diseased and injured organs because of a severe shortage of donor organs available for transplantation. Therapeutic cloning, where the nucleus from a donor cell is transferred into an enucleated oocyte in order to extract pluripotent embryonic stem cells, offers a potentially limitless source of cells for replacement therapy. Scientists in the field of tissue engineering apply the principles of cell transplantation, material science, and engineering to construct biological substitutes that will restore and maintain normal function in diseased and injured tissues. The present chapter reviews recent advances that have occurred in therapeutic cloning and tissue engineering and describes applications of these new technologies that may offer novel therapies for patients with end-stage organ failure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15255761     DOI: 10.1146/annurev.bioeng.6.012204.115707

Source DB:  PubMed          Journal:  Annu Rev Biomed Eng        ISSN: 1523-9829            Impact factor:   9.590


  3 in total

1.  Erythropoietin producing cells for potential cell therapy.

Authors:  Tamer Aboushwareb; Fernanda Egydio; Lauren Straker; Kenneth Gyabaah; Anthony Atala; James J Yoo
Journal:  World J Urol       Date:  2008-07-08       Impact factor: 4.226

2.  Transplanted bone marrow stem cells relocate to infarct penumbra and co-express endogenous proliferative and immature neuronal markers in a mouse model of ischemic cerebral stroke.

Authors:  Xue-mei Zhang; Fang Du; Dan Yang; Chun-jiang Yu; Xiang-nan Huang; Wei Liu; Jin Fu
Journal:  BMC Neurosci       Date:  2010-10-25       Impact factor: 3.288

3.  New era in health care: tissue engineering.

Authors:  S Parveen; K Krishnakumar; Sk Sahoo
Journal:  J Stem Cells Regen Med       Date:  2006-12-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.